Vorzeitiger Abbruch randomisierter kontrollierter Studien: Vorteilsbedingter Therapieeffekt

Translated title of the contribution: Randomized controlled trials terminated prematurely: Beneficial therapy effects

L. A. Kluth, M. Rink, S. A. Ahyai, M. Fisch, S. F. Shariat, P. Dahm

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Randomized controlled trials (RCTs) stopped prematurely for beneficial therapy effects are becoming increasingly more prevalent in the urological literature and often receive great attention in the public and medical media. Urologists who practice evidence-based medicine should be aware of the potential bias and the different reasons why and how early termination of RCTs can and will affect the results. This review provides insights into the challenges clinical urologists face by interpreting the results of prematurely terminated RCTs.

Translated title of the contributionRandomized controlled trials terminated prematurely: Beneficial therapy effects
Original languageGerman
Pages (from-to)1080-1083
Number of pages4
JournalUrologe - Ausgabe A
Issue number8
StatePublished - Aug 2013

Bibliographical note

Copyright 2013 Elsevier B.V., All rights reserved.


  • Bias, epidemiological
  • Evidence-based medicine
  • Study termination, premature
  • Therapy effect


Dive into the research topics of 'Randomized controlled trials terminated prematurely: Beneficial therapy effects'. Together they form a unique fingerprint.

Cite this